精氨酸
整合素
癌症研究
医学
甘氨酸
对偶(语法数字)
药理学
癌症
生物信息学
化学
生物化学
内科学
生物
氨基酸
受体
艺术
文学类
作者
Bojana Bogdanović,Daniel Fagret,Cathérine Ghezzi,Christopher Montemagno
出处
期刊:Pharmaceuticals
[Multidisciplinary Digital Publishing Institute]
日期:2024-11-20
卷期号:17 (11): 1556-1556
被引量:52
摘要
Integrins, an important superfamily of cell adhesion receptors, play an essential role in cancer progression, metastasis, and angiogenesis, establishing them as prime targets for both diagnostic and therapeutic applications. Despite their significant potential, integrin-targeted therapies have faced substantial challenges in clinical trials, including variable efficacy and unmet high expectations. Nevertheless, the consistent expression of integrins on tumor and stromal cells underscores their ongoing relevance and potential. Traditional RGD-based imaging and therapeutic agents have faced limitations, such as inconsistent target expression and rapid systemic clearance, which have reduced their effectiveness. To overcome these challenges, recent research has focused on advancing RGD-based strategies and exploring innovative solutions. This review offers a thorough analysis of the latest developments in the RGD-integrin field, with a particular focus on addressing previous limitations. It delves into new dual-targeting approaches and cutting-edge RGD-based agents designed to improve both tumor diagnosis and therapeutic outcomes. By examining these advancements, this review illuminates new pathways for enhancing the specificity and efficacy of integrin-targeted therapies, paving the way for more effective cancer diagnosis and treatment strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI